About Index Trending news
Lists
Pricing
Oragenics

Oragenics

Oragenics

We are a biopharmaceutical company focused primarily on oral probiotics products and novel antibiotics for humans and companion pets.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$3,000,000
Venture capital
$4,670,000
Employees

Unknown size

Locations
HQ
Headquarters
$3,000,000 Post-IPO equity
businesswire

Oragenics Announces Completion of Second Closing of $3.0 Million Preferred Stock Private Placement